Guardant Health shares are trading higher after BTIG maintained its Buy rating on the stock and raised its price target from $160 to $190.
Guardant Health shares are trading higher after BTIG maintained its Buy rating on the stock and raised its price target from $160 to $190.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.